Vapotherm Inc
OTC:VAPO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vapotherm Inc
OTC:VAPO
|
US |
|
J
|
Jiangsu Akcome Science & Technology Co Ltd
SZSE:002610
|
CN |
|
Global Ship Lease Inc
NYSE:GSL
|
UK |
|
V
|
Vistra Corp
SWB:0V6
|
US |
|
China TransInfo Technology Co Ltd
SZSE:002373
|
CN |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
FINEOS Corporation Holdings PLC
ASX:FCL
|
IE |
|
L
|
Lianhua Supermarket Holdings Co Ltd
HKEX:980
|
CN |
|
D
|
Daiei Kankyo Co Ltd
TSE:9336
|
JP |
|
Educational Development Corp
NASDAQ:EDUC
|
US |
|
T
|
Tri-Mode System (M) Bhd
KLSE:TRIMODE
|
MY |
|
Federal Mogul Izmit Piston ve Pim Uretim Tesisleri AS
IST:FMIZP.E
|
TR |
|
SenseTime Group Inc
HKEX:20
|
CN |
|
KROMI Logistik AG
XETRA:K1R
|
DE |
|
B
|
Bowler Metcalf Ltd
JSE:BCF
|
ZA |
|
Mayfield Childcare Ltd
ASX:MFD
|
AU |
Vapotherm Inc
Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. The company is headquartered in Exeter, New Hampshire and currently employs 510 full-time employees. The company went IPO on 2018-11-14. The firm is focused on the care of patients of all ages suffering from the respiratory distress often associated with complex lung diseases, such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company offers four versions of its Precision Flow systems, which includes Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its digital solutions are focused on at home patient monitoring. The firm also provides various clinical solutions.
Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. The company is headquartered in Exeter, New Hampshire and currently employs 510 full-time employees. The company went IPO on 2018-11-14. The firm is focused on the care of patients of all ages suffering from the respiratory distress often associated with complex lung diseases, such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company offers four versions of its Precision Flow systems, which includes Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its digital solutions are focused on at home patient monitoring. The firm also provides various clinical solutions.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
